Document is current
Any future updates will be listed below
-
Authors
Kunte, Sophie Carina https://orcid.org/0009-0003-3175-952X
Wenter, Vera U.
Holzgreve, Adrien
Sheikh, Gabriel T.
Widjaja, Liam
Gildehaus, Franz Josef
Lindner, Simon
Schirrmacher, Ralf
Spitzweg, Christine
Auernhammer, Christoph J.
Werner, Rudolf A.
Zacherl, Mathias J.
-
Funding
Funding for this research was provided by:
Bayerisches Zentrum für Krebsforschung
Deutsche Forschungsgemeinschaft (545058105)
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 2 June 2025
Revised: 2 September 2025
Accepted: 8 September 2025
First Online: 29 September 2025
Declarations
:
: The analysis was performed in compliance with the principles of the Declaration of Helsinki and was approved by the institutional ethics committee of the Ludwig-Maximilians-University of Munich (IRB #21–0102 and #24–0982).
: Waved by the ethics board.
: Not applicable.
: AH: Personal fees from ABX advanced biochemical compounds outside the submitted work. RAW: speaker honoraria from Novartis/AAA and PentixaPharm, advisory board work for Novartis/AAA and Bayer. MJZ: speaker honoraria from Novartis, SIRTEX and Terumo, advisory board for Boston Scientific.
